HBC Pharmaceuticals Private Limited
About HBC Pharmaceuticals Private Limited
Data last updated:
HBC Pharmaceuticals Private Limited is a private limited company based in Gandhinagar, Gujarat, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 15 March 2023.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U21001GJ2023PTC139205. Its GSTIN is 24AAGCH7086Q1ZU (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Hasmukh Shankerbhai Patel and Yatharth Hasmukhbhai Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sector 25, Gandhinagar, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.68 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹3.61 Cr (net margin -98%) and EBITDA of -₹3.59 Cr (EBITDA margin -97.5%).
Company details
Contact details
HBC Pharmaceuticals Private Limited's registered office is in Gandhinagar, Gujarat.
- Registered AddressPlot No B/218, GIDC Electronic Estate Sector 25, Gandhinagar, Gujarat, India – 382016
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of HBC Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of HBC Pharmaceuticals Private Limited, buy the company report.
Financials of HBC Pharmaceuticals Private Limited
FY 2025 filings availableHBC Pharmaceuticals Private Limited reported revenue of ₹3.68 Cr (up 194% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 194% in the latest year. EBITDA fell 167% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹3.59 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹3.61 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -97.5% | ||
| Net Profit Margin | -98% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of HBC Pharmaceuticals Private Limited, buy the company report.
Board of directors of HBC Pharmaceuticals Private Limited
HBC Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hasmukh Shankerbhai Patel Also directs: Takshraj Buildcon LLP, Injexa Lifesciences Private Limited, HBC Lifesciences Private Limited and 4 more | Director | 15 Mar 2023 | 3 Years 7 Months | Current |
| Yatharth Hasmukhbhai Patel | Director | 15 Mar 2023 | 3 Years 7 Months | Current |
| Himanshu Shankerlal Patel Also directs: Takshraj Buildcon LLP, Injexa Lifesciences Private Limited, HBC Lifesciences Private Limited and 5 more | Director | 31 Jan 2025 | 1 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving HBC Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for HBC Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
HBC Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAGCH7086Q1ZU | Gujarat | Active | 03 May 2023 |
To see the full GST registrations and return filing status of HBC Pharmaceuticals Private Limited, buy the company report.
Recent activity
HBC Pharmaceuticals Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Himanshu Shankerlal Patel was appointed as Director on 31 Jan 2025.
Frequently asked questions
HBC Pharmaceuticals is an active private limited company based in Gandhinagar, Gujarat, India. The company works in paper and paper products, within the paper industry. It was incorporated on 15 March 2023 (3+ years old) and is registered under CIN U21001GJ2023PTC139205.
HBC Pharmaceuticals has 3 current directors:
- Hasmukh Shankerbhai Patel - Director
- Yatharth Hasmukhbhai Patel - Director
- Himanshu Shankerlal Patel - Director
The latest financial statements of HBC Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of HBC Pharmaceuticals is 24AAGCH7086Q1ZU, registered in Gujarat.
The CIN (Corporate Identification Number) of HBC Pharmaceuticals is U21001GJ2023PTC139205. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
HBC Pharmaceuticals was incorporated on 15 March 2023, making it 3+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Himanshu Shankerlal Patel was appointed as Director on 31 Jan 2025. Hasmukh Shankerbhai Patel was appointed as Director on 15 Mar 2023. Yatharth Hasmukhbhai Patel was appointed as Director on 15 Mar 2023.
The registered office of HBC Pharmaceuticals is at Plot No B218, GIDC Electronic Estate Sector 25, Gandhinagar, Gujarat, India – 382016.
HBC Pharmaceuticals operates in the paper industry, in the paper and paper products segment.
HBC Pharmaceuticals can be reached at its registered office: Plot No B218, GIDC Electronic Estate Sector 25, Gandhinagar, Gujarat, India – 382016.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
